Estrogen withdrawal, increased breast cancer risk and the KRAS-variant

The KRAS-variant is a biologically functional, microRNA binding site variant, which predicts increased cancer risk especially for women. Because external exposures, such as chemotherapy, differentially impact the effect of this mutation, we evaluated the association of estrogen exposures, breast can...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Cycle
Asıl Yazarlar: McVeigh, Terri P, Jung, Song-Yi, Kerin, Michael J, Salzman, David W, Nallur, Sunitha, Nemec, Antonio A, Dookwah, Michelle, Sadofsky, Jackie, Paranjape, Trupti, Kelly, Olivia, Chan, Elcie, Miller, Nicola, Sweeney, Karl J, Zelterman, Daniel, Sweasy, Joann, Pilarski, Robert, Telesca, Donatello, Slack, Frank J, Weidhaas, Joanne B
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis 2015
Konular:
Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4614527/
https://ncbi.nlm.nih.gov/pubmed/25961464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2015.1041694
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller